{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:58:34Z","timestamp":1781326714306,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01EY036107"],"award-info":[{"award-number":["R01EY036107"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118394","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:31:11Z","timestamp":1764390671000},"page":"118394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological properties exhibited by 1,2,3-triazole based Grp94-selective inhibitors"],"prefix":"10.1016","volume":"303","author":[{"given":"Hao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.E.","family":"Huard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A.","family":"Chalfoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Adulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel L.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-3480","authenticated-orcid":false,"given":"Brian S.J.","family":"Blagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.118394_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00024382-199901000-00001","article-title":"Heat shock proteins: facts, thoughts, and dreams","volume":"11","author":"De Maio","year":"1999","journal-title":"Shock Augusta Ga"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118394_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14202\/vetworld.2015.46-51","article-title":"Heat shock proteins: a therapeutic target worth to consider","volume":"8","author":"Dubey","year":"2015","journal-title":"Vet. World"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118394_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"6709","key":"10.1016\/j.ejmech.2025.118394_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/24550","article-title":"Hsp90 as a capacitor for morphological evolution","volume":"396","author":"Rutherford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118394_bib5","volume":"vol. 38","author":"Sanchez","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118394_bib6","first-page":"4","volume":"vol.425","author":"Kamal","year":"2003"},{"key":"10.1016\/j.ejmech.2025.118394_bib7","unstructured":"Kim, Y. S.; Alarcon, S. V.; Lee, S. Update on Hsp90 Inhibitors in Clinical Trial. vol. 14."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118394_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118394_bib9","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1021\/ja303477g","article-title":"Development of a Grp94 inhibitor","volume":"134","author":"Duerfeldt","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"10.1016\/j.ejmech.2025.118394_bib10","doi-asserted-by":"crossref","first-page":"48330","DOI":"10.1074\/jbc.M308661200","article-title":"Structure of the N-Terminal domain of GRP94","volume":"278","author":"Soldano","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118394_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ncb1001-891","article-title":"Endoplasmic reticulum chaperone Gp96 is required for innate immunity but not cell viability","volume":"3","author":"Randow","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118394_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acschembio.7b01083","article-title":"Trifunctional high-throughput screen identifies promising scaffold to inhibit Grp94 and treat myocilin-associated glaucoma","volume":"13","author":"Huard","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"62","key":"10.1016\/j.ejmech.2025.118394_bib13","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1002\/chem.201703398","article-title":"Second generation Grp94-Selective inhibitors provide opportunities for the inhibition of metastatic cancer","volume":"23","author":"Crowley","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.118394_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101188","article-title":"Myocilin misfolding and glaucoma: a 20-Year update","volume":"95","author":"Saccuzzo","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118394_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18344-4","article-title":"Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma","volume":"7","author":"Stothert","year":"2017","journal-title":"Sci. Rep."},{"issue":"48","key":"10.1016\/j.ejmech.2025.118394_bib16","doi-asserted-by":"crossref","first-page":"40661","DOI":"10.1074\/jbc.M112.384800","article-title":"Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism","volume":"287","author":"Suntharalingam","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118394_bib17","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1093\/hmg\/ddu367","article-title":"Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma","volume":"23","author":"Stothert","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118394_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48751-8","article-title":"Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation","volume":"9","author":"Huard","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118394_bib19","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1021\/acs.jmedchem.6b00085","article-title":"Development of glucose regulated protein 94-Selective inhibitors based on the BnIm and radamide scaffold","volume":"59","author":"Crowley","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118394_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1335","article-title":"Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2","volume":"9","author":"Patel","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118394_bib21","first-page":"1071","article-title":"Glaucomatous MYOC mutations activate the IL-1\/NF-\u03baB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells","volume":"21","author":"Itakura","year":"2015","journal-title":"Mol. Vis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:46:54Z","timestamp":1781326014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"alternative-id":["S0223523425011596"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118394","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological properties exhibited by 1,2,3-triazole based Grp94-selective inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118394"}}